BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27209232)

  • 1. Quinazolinones-Phenylquinoxaline hybrids with unsaturation/saturation linkers as novel anti-proliferative agents.
    Palem JD; Alugubelli GR; Bantu R; Nagarapu L; Polepalli S; Jain SN; Bathini R; Manga V
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3014-3018. PubMed ID: 27209232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential anti-proliferative agents from 1,4-benzoxazinone-quinazolin-4(3H)-one templates.
    Bollu R; Banu S; Kasaboina S; Bantu R; Nagarapu L; Polepalli S; Jain N
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5481-5484. PubMed ID: 29089233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design, synthesis and anti-proliferative evaluation of novel 1,4-benzoxazine-[1,2,3]triazole hybrids.
    Bollu R; Palem JD; Bantu R; Guguloth V; Nagarapu L; Polepalli S; Jain N
    Eur J Med Chem; 2015 Jan; 89():138-46. PubMed ID: 25462234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and Discovery of Novel Quinoxaline Derivatives as Dual DNA Intercalators and Topoisomerase II Inhibitors.
    Eissa IH; El-Naggar AM; El-Sattar NEAA; Youssef ASA
    Anticancer Agents Med Chem; 2018; 18(2):195-209. PubMed ID: 28699490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel quinazolin-4(3H)-one/Schiff base hybrids as antiproliferative and phosphodiesterase 4 inhibitors: design, synthesis, and docking studies.
    Abdel-Rahman HM; Abdel-Aziz M; Canzoneri JC; Gary BD; Piazza GA
    Arch Pharm (Weinheim); 2014 Sep; 347(9):650-7. PubMed ID: 24985336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design, synthesis and anti-proliferative evaluation of novel benzosuberone tethered with hydrazide-hydrazones.
    Yadagiri B; Holagunda UD; Bantu R; Nagarapu L; Guguloth V; Polepally S; Jain N
    Bioorg Med Chem Lett; 2014 Nov; 24(21):5041-4. PubMed ID: 25264072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and cytotoxicity testing of novel 2-(3-substituted-6-chloro-1,1-dioxo-1,4,2-benzodithiazin-7-yl)-3-phenyl-4(3H)-quinazolinones.
    Pomarnacka E; Maruszak M; Langowska K; Reszka P; Bednarski PJ
    Arch Pharm (Weinheim); 2008 Aug; 341(8):485-90. PubMed ID: 18618486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel benzothiazine-piperazine derivatives by peptide-coupling as potential anti-proliferative agents.
    Venkatesh R; Kasaboina S; Bidayat D; Nikhil Kumar U; Jain N; Tangeda SJ; Bantu R; Janardhan S; Nagarapu L
    Bioorg Med Chem Lett; 2017 Jan; 27(2):354-359. PubMed ID: 27964883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, in vitro antitumour activity, and molecular docking study of novel 2-substituted mercapto-3-(3,4,5-trimethoxybenzyl)-4(3H)-quinazolinone analogues.
    El-Azab AS; Abdel-Aziz AA; Ghabbour HA; Al-Gendy MA
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1229-1239. PubMed ID: 28948843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antitumor evaluation of trimethoxyanilides based on 4(3H)-quinazolinone scaffolds.
    Mohamed MA; Ayyad RR; Shawer TZ; Abdel-Aziz AA; El-Azab AS
    Eur J Med Chem; 2016 Apr; 112():106-113. PubMed ID: 26890117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and docking studies of novel 1,2-dihydro-4-hydroxy-2-oxoquinoline-3-carboxamide derivatives as a potential anti-proliferative agents.
    Banu S; Bollu R; Bantu R; Nagarapu L; Polepalli S; Jain N; Vangala R; Manga V
    Eur J Med Chem; 2017 Jan; 125():400-410. PubMed ID: 27688193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lemon Juice Mediated Synthesis of 3-Substituted Quinazolin-4(3H)-Ones and their Pharmacological Evaluation.
    Prasad MG; Lakshmi CV; Katari NK; Jonnalagadda SB; Pal M
    Anticancer Agents Med Chem; 2019; 19(16):2001-2009. PubMed ID: 31340741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of derivatives of 6(7)-amino-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: novel, hypoxia-selective HIF-1α inhibitors with strong antiestrogenic potency.
    Buravchenko GI; Scherbakov AM; Dezhenkova LG; Bykov EE; Solovieva SE; Korlukov AA; Sorokin DV; Monzote Fidalgo L; Shchekotikhin AE
    Bioorg Chem; 2020 Nov; 104():104324. PubMed ID: 33142432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, antitumor activity and molecular docking study of some novel 3-benzyl-4(3H)quinazolinone analogues.
    Al-Suwaidan IA; Abdel-Aziz AA; Shawer TZ; Ayyad RR; Alanazi AM; El-Morsy AM; Mohamed MA; Abdel-Aziz NI; El-Sayed MA; El-Azab AS
    J Enzyme Inhib Med Chem; 2016; 31(1):78-89. PubMed ID: 25815668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of certain novel N-(2-(2-(2-oxoindolin-3-ylidene)hydrazinecarbonyl)phenyl)-benzamides and 3-(2-oxoindolin-3-ylideneamino)-2-substituted quinazolin-4(3H)-ones as CFM-1 analogs: design, synthesis, QSAR analysis and anticancer activity.
    Alafeefy AM; Ashour AE; Prasad O; Sinha L; Pathak S; Alasmari FA; Rishi AK; Abdel-Aziz HA
    Eur J Med Chem; 2015 Mar; 92():191-201. PubMed ID: 25555142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and molecular docking studies of 2-(furan-2-yl)quinazolin-4-one derivatives as potential antiproliferative agents.
    Ahmed MF; Belal A
    Arch Pharm (Weinheim); 2015 Jul; 348(7):487-97. PubMed ID: 25921702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of (E)-2-(2-arylhydrazinyl)quinoxalines, a promising and potent new class of anticancer agents.
    Rodrigues FA; Bomfim Ida S; Cavalcanti BC; Pessoa Cdo Ó; Wardell JL; Wardell SM; Pinheiro AC; Kaiser CR; Nogueira TC; Low JN; Gomes LR; de Souza MV
    Bioorg Med Chem Lett; 2014 Feb; 24(3):934-9. PubMed ID: 24398294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anticancer activity of N-substituted 2-arylquinazolinones bearing trans-stilbene scaffold.
    Mahdavi M; Pedrood K; Safavi M; Saeedi M; Pordeli M; Ardestani SK; Emami S; Adib M; Foroumadi A; Shafiee A
    Eur J Med Chem; 2015 May; 95():492-9. PubMed ID: 25847767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of the antiproliferative activity of novel isoindolo[2,1-a]quinoxaline and indolo[1,2-a]quinoxaline derivatives.
    Desplat V; Moreau S; Belisle-Fabre S; Thiolat D; Uranga J; Lucas R; de Moor L; Massip S; Jarry C; Mossalayi DM; Sonnet P; Déléris G; Guillon J
    J Enzyme Inhib Med Chem; 2011 Oct; 26(5):657-67. PubMed ID: 21250818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, antitumor and antimicrobial activity of some new 6-methyl-3-phenyl-4(3H)-quinazolinone analogues: in silico studies.
    Alanazi AM; Abdel-Aziz AA; Shawer TZ; Ayyad RR; Al-Obaid AM; Al-Agamy MH; Maarouf AR; El-Azab AS
    J Enzyme Inhib Med Chem; 2016 Oct; 31(5):721-35. PubMed ID: 26162029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.